Press Releases

Oct 9, 2015

Armed With FDA Orphan Drug Status in the U.S., PharmaCyte Biotech Now Securing Europe for Pancreatic Cancer Treatment

Oct 7, 2015

PharmaCyte Biotech CEO in Europe to Secure Orphan Designation With the EMA

Oct 5, 2015

Imaging Endpoints Founder Discusses Role in PharmaCyte Biotech’s Unique Approach to Pancreatic Cancer for Upcoming Clinical Trial

Oct 1, 2015

PharmaCyte Biotech Retains Industry Expert to Monitor Short Sellers and Market Makers

Sep 30, 2015

PharmaCyte Biotech Moves Closer to Revealing Plan to Address Unmet Medical Need in Phase 2b Clinical Trial

Sep 28, 2015

PharmaCyte Biotech’s Encapsulation Technology Could Address Unmet Medical Need

Sep 25, 2015

PharmaCyte Biotech Hires Industry-Leading Firm to Assist With Investigational New Drug Application

Sep 22, 2015

PharmaCyte Biotech Discusses Pancreatic Cancer Treatment for Upcoming Phase 2b Human Clinical Trial

Sep 15, 2015

PharmaCyte Biotech Discusses Major Milestones Ahead of Phase 2b Clinical Trial in Pancreatic Cancer

Sep 9, 2015

PharmaCyte Biotech Begins Phase 2b Clinical Trial Push With Imaging Endpoints Contract for Radiological Imaging